Differentially regulated interferon response determines the outcome of Newcastle disease virus infection in normal and tumor cell lines.
Newcastle disease virus (NDV) is a negative-strand RNA virus with oncolytic activity against human tumors. Its effectiveness against tumors and safety in normal tissue have been demonstrated in several clinical studies. Here we show that the spread of NDV infection is drastically different in normal cell lines than in tumor cell lines and that the two cell types respond differently to beta interferon (IFN-beta) treatment. NDV rapidly replicated and killed HT-1080 human fibrosarcoma cells but spread poorly in CCD-1122Sk human skin fibroblast cells. Pretreatment with endogenous or exogenous IFN-beta completely inhibited NDV replication in normal cells but had little or no effect in tumor cells. Thus, the outcome of NDV infection appeared to depend on the response of uninfected cells to IFN-beta. To investigate their differences in IFN responsiveness, we analyzed and compared the expression and activation of components of the IFN signal transduction pathway in these two types of cells. The levels of phosphorylated STAT1 and STAT2 and that of the ISGF3 complex were markedly reduced in IFN-beta-treated tumor cells. Moreover, cDNA microarray analysis revealed significantly fewer IFN-regulated genes in the HT-1080 cells than in the CDD-1122Sk cells. This finding suggests that tumor cells demonstrate a less-than-optimum antiviral response because of a lesion in their IFN signal transduction pathway. The rapid spread of NDV in HT-1080 cells appears to be caused by their deficient expression of anti-NDV proteins upon exposure to IFN-beta.
Krishnamurthy
Sateesh
S
Department of Infectious Diseases, Mail Stop 330, St. Jude Children's Research Hospital, 332 N. Lauderdale, Memphis, TN 38105-2794, USA.
Takimoto
Toru
T
Scroggs
Ruth Ann
RA
Portner
Allen
A
D000818:Animals; D002460:Cell Line; D015967:Gene Expression Regulation, Viral; D007372:Interferons / Q000096:biosynthesis* / Q000276:immunology; D009521:Newcastle Disease / Q000503:physiopathology*; D009522:Newcastle disease virus / Q000502:physiology*; D014407:Tumor Cells, Cultured / Q000378:metabolism / Q000821:virology; D014764:Viral Proteins / Q000235:genetics / Q000502:physiology*
D014764:Viral Proteins; D007372:Interferons